Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis

International Angiology

Volumn 15, Issue 3, 1996, Pages 240-244

  Mangiafico, Roberto Antonio ^a   Malatino, Lorenzo Salvatore ^a   Santonocito, Maurizio ^a   Spada, Rosario Sebastiano ^a   Polizzi, Gaetano ^a   Tamburino, Giacomo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Endothelin 1; Hypercholesterolemia

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; RADIOIMMUNOASSAY; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENDOTHELIN-1; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; TRIGLYCERIDES;

EID: 0029850775     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolaemia and atherosclerosis. Circ Res 1989;64:900-14.
2. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolaemia. Hypertension 1991;18(Suppl II):II-90-II-99.
3. Leung W-H, Lau C-P, WOng C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993;341:1496-500.
4. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989;79:287-91.
5. Yasue H, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Response of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990;81:482-90.
6. Vita JA, Trasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81:491-7.
7. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992;340:14320-2.
8. Cohen RA, Zitnay KM, Haudenschild CC, Cunningam LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolaemia in pig coronary arteris. Circ Res 1988;63:903-10.
9. Henry PD. Hyperlipidemic arterial dysfunction. Circulation 1990;63:903-10.
10. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium derived relaxing factor. Nature 1987;327:524-6.
11. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;ii:997-1000.
12. Moncada S, Palmer RMJ, Higgs AE. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-49.
13. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolaemic patients. Circulation 1993;88:2541-7.
14. Verheuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MO, Herman AG. Effect of hypercholesterolaemia on vascular reactivity in the rabbit. Circ Res 1986;58:783-9.
15. Galle J, Nulsch A, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscl Thromb 1991;11:198-203.
16. Jeserich M, Münzel T, Just H, Drexler H. Reduced plasma L-arginine in hypercholesterolaemia. Lance 1992;339:561.
17. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994;90:35-41.
18. Lüsher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993;87(Suppl V):V-36-V-44.
19. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
20. Masaki T, Yanagisawa M, Gotok K. Physiology and pharmacology of endothelins. Med Res Rev 1992;12:391-421.
21. Hirata Y, Takagy Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225-8.
22. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852-4.
23. Haynes WG, Webb DJ. The endothelin family of peptides: local hormones with diverse role in health and disease? Clin Sci 1993;84:485-500.
24. Webb DJ, Haynes WG. Endothelins come of age. Lancet 1993;342:1439-40.
25. Lerman A, Edwards BS, Hallet JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
26. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end stage heart failure and following cardiac transplantation. J Am Coll Cardiol 1992;20:849-53.
27. Davenport AP, Ashby MJ, Easton P et al. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990;78:261-4.
28. Lerman A, Webster MWI, Chesebro JH et al. Circulating and tissue immunoreactivity in hypercholesterolemic pigs. Circulation 1993;88:2923-8.
29. Arendt RM, Wilbert-Lamper U, Heucke L. Increased plasma endothelin in patients with hyperlipoproteinemia and stable or unstable angina. Circulation 1990;82(Suppl III):III-248 (abstract).
30. Zeiher AM, Ihling C, Pistorius K, Goebel H, Schaefer H-E. Hypercholesterolemia is associated with enhanced tissue endothelin-1 immunoreactivity in the vascular wall in humans. Circulation 1994;90:576 (abstract).
31. Tanner FC, Boulanger CM, Lüsher TF. Endothelium-derived nitric oxide, endothelin and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. Semin Thromb Hemost 1993;19:167-75.
32. Patrignani P, Daffonchio L, Hernandez A, De Caterina R, Pelosi G, Patrone C. Release of contracting autacoids by aortae of normal and atherosclerotic rabbits. J Cardiovasc Pharmacol 1992;20(Suppl 12):S-208-S-210.
33. Merkel LA, Bilder GE. Modulation of vascular reactivity by vasoactive peptide in aortic rings from hypercholesterolemic rabbits. Eur J Pharmacol 1992;222:175-9.
34. Boulanger CM, Tanner FC, Bea ML, Hahn AWA, Werner A, Lüsher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992;70:1191-7.
35. Horio T, Kohno M, Yasunari K et al. Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells. Atherosclerosis 1993;101:185-90.
36. Wagner OF, Christ G, Wojta J et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-88.
37. Yang Z, Richard D, Von Segesser L et al. Threshold concentrations of endothelin-1 potentiate contraction to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 1990;82: 188-95.
38. Yoshida K, Yasujima M, Kohzuki M, Kanazawa M, Yoshinaga K, Abe K. Endothelin-1 augments pressor response to angiotensin II infusion in rats. Hypertension 1992;20:292-7.
39. Lüsher TF. Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. Eur Heart J 1989;10:847-57.
40. Lüsher TF, Yang Z, Diederich D, Bühler FR. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion. J Cardiovasc Pharmacol 1989;14(Suppl 6): S63-S69.